Short answer
Cannabis does not "boost" the immune system. THC and other cannabinoids act on CB2 receptors, which sit mainly on immune cells, and in laboratory and animal studies they mostly suppress immune activity and inflammation. In people, the best evidence is for the THC:CBD spray nabiximols (Sativex), which is probably effective for self-reported spasticity in multiple sclerosis; for most other autoimmune diseases human evidence is still lacking.
Not medical advice
This article is general education, not medical advice. If you have an autoimmune disease or a weakened immune system, or take immunosuppressants (for example after a transplant), talk to your doctor or pharmacist before using cannabis. CBD can interact with other medications, and cannabis should not replace prescribed treatment.
Table of Contents
Key Takeaway
Cannabis interacts with the immune system through CB2 receptors on immune cells. In lab and animal studies it mostly dampens immune activity, but evidence that it helps autoimmune conditions in people is still limited.
The endocannabinoid system and immunity
The endocannabinoid system (ECS) is a cell-signaling network discovered in the late 1980s and 1990s during THC research. It consists of endocannabinoids, receptors (CB1 and CB2), and enzymes. While CB1 receptors are concentrated in the brain, CB2 receptors are found predominantly on immune cells including macrophages, B-cells, T-cells, and natural killer cells.
This distribution suggests the ECS evolved partly as an immune regulatory mechanism. When you consume cannabis, phytocannabinoids like THC and CBD interact with these receptors, which explains why cannabis can have pronounced effects on immune function and inflammatory responses.
CB2 receptors and immune cells
CB2 receptors are expressed on virtually every type of immune cell. In laboratory and animal studies, CB2 activation tends to reduce pro-inflammatory cytokines and dampen immune cell activity.
This makes cannabinoids interesting to researchers studying conditions with excessive inflammation, such as autoimmune diseases, allergies, and chronic inflammatory conditions. THC binds directly to both CB1 and CB2 receptors, while CBD binds them only weakly and is thought to act mainly through other pathways.
Cannabis as an immunomodulator
Researchers often describe cannabinoids as immunomodulators, but in most laboratory and animal studies the net effect is immunosuppressive. In mice, THC triggers the death of T cells and dendritic cells and suppresses T-cell-mediated immune responses. That is why cannabinoids are being studied for overactive immune conditions — and also why you should not assume cannabis leaves your ability to fight infections untouched.
CBD has also shown immunomodulatory properties in preclinical studies, reducing T-cell proliferation and inflammatory cytokine production. Whether these effects occur at the doses people actually take, and whether they help or harm, has not been established in humans.
Autoimmune disease research
Autoimmune diseases represent one of the most promising areas for cannabis research. Conditions like rheumatoid arthritis, multiple sclerosis, and Crohn disease involve chronic inflammation from an overactive immune system, making cannabinoids natural candidates for therapeutic investigation.
Clinical evidence is limited. In multiple sclerosis, a 2014 American Academy of Neurology guideline found the THC:CBD spray nabiximols (Sativex) probably effective for self-reported spasticity, but probably ineffective on objective spasticity measures. For Crohn's disease, trials show symptom relief without less gut inflammation, and a Cochrane review called the effects uncertain. For rheumatoid arthritis and lupus, the evidence comes mostly from cell and animal studies.
Practical considerations
If you and your doctor decide to try cannabis, general harm-reduction advice applies: start low (about 2.5–5 mg THC, or less if you're new or sensitive), wait at least 2 hours before taking more, and increase slowly. Whether THC's immune-suppressing effects in laboratory studies raise infection risk in people has not been well studied, so take extra care if your immune system is already weakened.
Always consult your healthcare provider, especially if taking immunosuppressive medications. Monitor symptoms carefully and keep a dose journal to optimize your regimen over time. Cannabis should complement, not replace, conventional treatment.
Sources
- Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. "Cannabinoids as novel anti-inflammatory drugs." Future Medicinal Chemistry, 2009. PMC2828614
- Zhang W, et al. "Cannabinoids in immune system-related diseases: From bench to clinic." Chinese Medical Journal, 2026. PMC13186158
- National Center for Complementary and Integrative Health (NCCIH). "Cannabis (Marijuana) and Cannabinoids: What You Need To Know." NIH. nccih.nih.gov
- Kafil TS, Nguyen TM, MacDonald JK, Chande N. "Cannabis for the treatment of Crohn's disease." Cochrane Database of Systematic Reviews, 2018. PMC6517156
